Insulin glargine (GLAR) improves health related quality of life (HRQOL) in patients with type 2 diabetes (T2DM) inadequately controlled on sulfonylurea plus metformin (SU plus MET)

被引：0

|

作者：

Vinik, AI

Dailey, G

Zhang, Q

机构：

来源：

DIABETES | 2005年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A142 / A142

页数：1

相关论文

共 50 条

[41] WEIGHT- AND HEALTH-RELATED QUALITY OF LIFE (WRQOL AND HRQOL) WITH CANAGLIFLOZIN (CANA) VERSUS SITAGLIPTIN (SITA) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS (T2DM) ON BACKGROUND METFORMIN
Traina, S. B.
Ho, K. F.
[J]. VALUE IN HEALTH, 2013, 16 (07) : A448 - A448
[42] Patients with type 2 diabetes inadequately controlled on premixed insulin:: Effect of initiating insulin glargine plus oral agents on glycemic control in daily practice
Hammer, H
Schneider, K
Niemöller, E
[J]. DIABETES, 2005, 54 : A518 - A518
[43] Target Achievement and Quality Measure (QM) Attainment with Titrated Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM) as Add-on to Metformin (MET) plus Sitagliptin (SITA)
Seufert, Jochen
Aggarwal, Naresh
Bailey, Robert
Cao, Anjun
Fung, Albert
Pfeifer, Michael
Alba, Maria
Rodbard, Helena W.
[J]. DIABETES, 2016, 65 : A308 - A308
[44] Triple therapy in Type 2 diabetes: benefits of insulin glargine over rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients
Rosenstock, J
Sugimoto, D
Strange, P
Stewart, J
Rak, ES
Dailey, G
[J]. DIABETOLOGIA, 2004, 47 : A57 - A57
[45] Patients with type 2 diabetes inadequately controlled on premixed insulin: Effect of initiating insulin glargine plus oral agents on glycemic control in daily practice
Hammer, Harm
[J]. DIABETES, 2006, 55 : A115 - A115
[46] Comparison of the Effects of Insulin Detemir (IDet) and Insulin Glargine (IGlar) in Patients With Type 2 Diabetes (T2DM) in Turkey
Damci, Taner
Emral, Rifat
Svendsen, Anne Louise
Balkir, Tanzer
Vora, Jiten
[J]. DIABETES, 2013, 62 : A653 - A653
[47] Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy
Hollander, Priscilla
Sugimoto, Danny
Vlajnic, Aleksandra
Kilo, Charles
[J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1266 - 1271
[48] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy
Du, Jin
Liang, Li
Fang, Hui
Xu, Fengmei
Li, Wei
Shen, Liya
Mu, Yiming
[J]. DIABETES, 2016, 65 : A293 - A293
[49] The DPP-4 inhibitor, LAF237, improves glycemic control in patients with type 2 diabetes (T2DM) inadequately treated with metformin
Ahren, B
Gomis, R
Mills, D
Schweizer, A
[J]. DIABETES, 2004, 53 : A83 - A83
[50] Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study
Abdul-Ghani, Muhammad
Migahid, Osama
Megahed, Ayman
Adams, John
Triplitt, Curtis
DeFronzo, Ralph A.
Zirie, Mahmoud
Jayyousi, Amin
[J]. DIABETES CARE, 2017, 40 (03) : 325 - 331

← 1 2 3 4 5 →